Constantino Michael T. 4
4 · Humacyte, Inc. · Filed Oct 15, 2021
Insider Transaction Report
Form 4
Humacyte, Inc.HUMA
Constantino Michael T.
Director
Transactions
- Award
Stock Options (right to buy)
2021-10-13+13,000→ 13,000 totalExercise: $10.03Exp: 2031-10-13→ Common Stock (13,000 underlying)
Footnotes (1)
- [F1]The first 25% of the option becomes exercisable on October 13, 2022, after which 1/36 of the option will become exercisable on the 13th of each month through October 13, 2025.